Supreme Court Takes Up High-Stakes Legal Battle Over Access to Mifepristone Pill, Impacting Abortion Access in US

The Supreme Court on Wednesday took up a high-stakes legal battle that could have a nationwide impact on the availability of the drug mifepristone, commonly used for medication abortions. The court agreed to weigh appeals from the Biden administration and drugmaker Danco defending several Food and Drug Administration decisions that made it easier to access and use the mifepristone pill.

The case was brought by a group of doctors and medical associations opposed to abortion rights, and the outcome of the case could have far-reaching consequences by restricting how the drug mifepristone can be obtained, who can prescribe it and when it can be taken. The high court intervened in the case during an earlier stage, leaving the availability of mifepristone unchanged until the justices render a final decision, which is expected by the end of June.

The Supreme Court has a 6-3 conservative majority, and has previously shown hostility to abortion rights, overturning the landmark abortion rights ruling Roe v. Wade last year. The Biden administration is seeking to maintain access to the mifepristone pill, and the court’s decision could have a major impact on abortion access in the United States.

The court’s decision could have a major impact on abortion access in the United States, and the outcome of the case will be closely watched by both sides of the abortion debate. The court is expected to render a final decision by the end of June, and the ruling could have a major impact on the availability of mifepristone and abortion access across the country.